Department of Health Home A to Z Topics About the Department of Health Site Map Contact Us - Opens in a new window

Epidemiology Home

Health Topics (A-Z)

Related Links

Contact Us

   

Florida Department of HealthEPI UPDATE

A weekly publication by the Bureau of Epidemiology

For October 25, 2000

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jill H. Parker, MSP, Epi Update Editor

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

In this issue:

1. Florida Sees Its First Influenza for the Season

2. Flu Vaccine Update

3. Merlin Web-based Reporting System Training Update

4. Grand Rounds for October 31, 2000: "Epidemiology of Motorcycle Injuries during Bike Week 2000, Daytona Beach, Florida"

5. Health Professionals: Learn about Hepatitis C with an Online Educational Program from CDC

6. Weekly Arbovirus Activity Summary

7. New Legionellosis Case Report Form

8. Weekly Disease Table: Week 42


 

1. Florida Sees Its First Influenza for the Season

Jodi Baldy, Staff Epidemiologist, Bureau of Epidemiology

Surveillance for influenza officially began the first week in October although three reports of laboratory-confirmed cases of influenza A in the central Florida area were received the last week of September. This is not unusual, however, as the 1999-2000 season was preceded by a few reports in late August and September. Six laboratory-confirmed isolates have been reported to-date, five from central Florida (Hillsborough, Orange, and Pinellas counties) and one from Duval County. Two of the isolates have been subtyped as influenza A/ H1N1 – the new Caledonia-like strain. The other isolates have not been subtyped.

The Influenza Branch, CDC, conducts surveillance for influenza in the United States each year from October through mid May, and Florida is an important player in this system. There are four components to this system:

1)  World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) Collaborating Laboratories, which report the total number of respiratory specimens tested and the number positive for influenza by type and subtype each week

2)  122 Cities Mortality Reporting System for which vital statistics offices of 122 cities report the total number of death certificates filed and the number of those for which pneumonia was identified as the underlying cause of death or for which influenza was listed as the underlying or as a contributing cause of death. Four Florida cities are in this program (St. Petersburg, Jacksonville, Miami, Tampa).

3)  State and Territorial Epidemiologists Reports for which state health departments report the estimated level of influenza activity in their state each week - when activity occurs, it is reported as sporadic, regional, or widespread.

4)  U.S. Influenza Sentinel Physicians Surveillance Network, in which Florida has enrolled over 100 physicians who report each week the total number of patients seen and the number of those patients with influenza-like illness by age group. They also send in specimens for viral identification.

 

2. Flu Vaccine Update

(The following information was derived from the CDC web site and submitted by Al Sulkes, Bureau of Immunization, for publication in the Epi Update.)

The Department of Health and Human Services, the Food and Drug Administration, and the Centers for Disease Control and Prevention are working closely with vaccine manufacturers to facilitate the availability of safe and effective influenza vaccine for the upcoming flu season. Influenza vaccine manufacturers have told FDA and CDC to expect delays in flu vaccine shipments and that it is possible there will be reductions of available influenza virus vaccine for the 2000-01 season.

The total amount of vaccine available for the influenza season is uncertain at this time. However, both FDA and CDC are actively working with manufacturers to determine how much and when vaccine will be available. The amount of available flu vaccine will become clearer over the next two months.

CDC has a flu vaccine supply web site to help health professionals find sources of this year’s flu vaccine. CDC has also available a cybercast on the 2000-2001 Update on Preparing for Next Influenza Pandemic.

Influenza Vaccine: Questions and Answers

Who is at highest risk for complications from influenza?

Persons at high risk for complications from influenza should receive annual vaccination and include the following:

  • Persons aged 65 years and older;
  • Residents of nursing homes and other chronic-care facilities with residents of any age who have chronic medical conditions;
  • Adults and children aged 6 months and older who have chronic pulmonary or cardiovascular disease, including asthma;
  • Adults and children aged 6 months and older who have required regular medical follow-up or hospitalization during the past year because of chronic metabolic diseases (including diabetes mellitus), kidney dysfunction, blood disorders (hemoglobinopathies), or immune system problems (immunocompromised e.g. HIV infection, immunosuppressed by medication, chemotherapy or radiation therapy);
  • Children and teenagers (aged 6 months to 18 years) who are receiving long-term aspirin therapy and therefore might be at risk for developing Reye Syndrome after influenza infection;
  • Women who will be in the second or third trimester of pregnancy during the influenza season.

Will those at highest risk from complications be able to get a flu shot?

It is important to stress that FDA, CDC and vaccine manufacturers are confident that vaccine will be available to vaccinate those at highest risk of complications from influenza, including those over 65, those who are immunosuppressed and others.

If a substantial shortfall of vaccine were to occur, the ACIP and CDC would provide modified recommendations for the 2000-2001 influenza season that emphasize vaccinating persons at highest risk of death from influenza (and the health care workers who take care of them) and then vaccinating, as the vaccine supply allows, the other groups for whom vaccine is traditionally recommended.

Why is there a delay in vaccine availability?

The amount of vaccine available is complicated by two important factors: 1) the yield for this year's influenza vaccine A(H3N2) component appears to be lower than expected which limits the supply that can be developed in time for this flu season and, 2) other manufacturing issues. Manufacturers are working closely with the FDA to address these issues.

Is there an alternative to flu shots?

Currently, four antiviral drugs are approved by the FDA to treat acute, uncomplicated influenza. These drugs are not a substitute for influenza vaccine and should not be used as such. The annual use of influenza vaccine is the primary means for minimizing adverse outcomes from influenza virus infections.

Over the course of the influenza season new information is expected to become available, and CDC and FDA will issue information updates.

3. Merlin Web-based Reporting System Training Update

Don Ward, Surveillance Section Administrator

This updates the Merlin training schedule published in last week’s Epi Update. New training dates include: Thursday, November 9-Duval County; Tuesday, November 14-Escambia County; and Wednesday November 15-Orange County. Negotiations are being concluded with Broward, Duval and Highlands counties.

Note: While we intend to provide training to everyone who wants to become a Merlin user, the primary audience for this initial training includes those who will be entering case reporting data (probably the same folks who now complete the 2016 forms) and their supervisors. Merlin training for all groups of users will be ongoing.

Updated schedules will be published in upcoming Epi Updates. To register or for additional information please contact John Werth.

The confirmed training schedule (valid as of 10/27/00) is as follows:

Date Location Building/Room

November 9 (Thurs.) Tallahassee 4052/215L

November 9 (Thurs.) Duval County

November 14 (Tues.) Escambia County

November 15 (Wed.) Orange County

November 17 (Fri.) Tallahassee 2585/110A

November 20 (Mon.) Tallahassee 4052/215L

November 28 (Tues.) Indian River CHD

November 29 (Wed.) Collier CHD

December 1 (Fri.) Tallahassee 2585/110A

December 4 (Mon.) Alachua CHD

December 8 (Fri.) Tallahassee 2585/110A

December 11 (Mon.) Tallahassee 4052/215L

December 12 (Tues.) Hillsborough CHD

December 15 (Fri.) Tallahassee 2585/110A

December 19 (Tues.) Tallahassee 4052/215L

 

4. Grand Rounds for October 31, 2000

"Epidemiology of Motorcycle Injuries during Bike Week 2000, Daytona Beach, Florida"

Dafna Kanny, PhD, Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention

11:00 AM - 12:00 PM EST

Abstract:

In March 2000, an annual motorcycle event in Daytona Beach, Florida resulted in a temporary local population increase from 64,000 residents to an estimated 600,000 people. Concomitantly, an unusually high number of motorcycle-related deaths were reported by the local and national press, making it the deadliest such event since its inception in 1937. The Volusia County Health Department and Florida Deparment of Health requested that the Centers for Disease Control and Prevention assist them in (a) determining the frequency, rate, and severity of unintentional injuries related to motorcycle crashes and other circumstances associated with the motorcycle event; and (b) identifying risk factors associated with these injury occurrences.

A CDC team was dispatched to Daytona Beach and abstracted data from the Volusia County Medical Examiner's Office, medical records from all Volusia County hospitals, EMS reports, and police crash reports from the period between March 2-13, 2000.

Additional Information:

Further details regarding the audio-conference call and PowerPoint files will be posted on the Bureau of Epidemiology Intranet web site. Be sure and register on-line for nursing CEUs and contact hours for environmental health professionals (when applicable). Information about upcoming topics and presenters will also be posted in future Epi Updates. If either of these access points is unavailable to you, please e-mail Melanie Black to request presentation materials.

Important:

While we realize you might not always be able to call in at 11:00 AM, it can be distracting to the speakers and others in the audience when participants dial-in throughout the hour. Please try to call in on time and remember to put your phones on mute so as not to disturb others. Thank you for your cooperation.

Future Grand Rounds Topics:

  1. November 27, 2000

2000 Dietary Guidelines for Americans

Nancy Spyker, Bureau of WIC and Nutritional Services

2. January 23, 2001

Varicella Surveillance

Savita Kumar, Epidemiologist, Palm Beach County Health Department

  1. February 27, 2001

Recreational Water-Related Outbreaks

Roberta Hammond, PhD., Biological Administrator II, Bureau of Environmental Epidemiology

 

5. Health Professionals: Learn about Hepatitis C with an Online Educational Program from CDC

(The following article was excerpted from IAC Express #202,October 25,2000, published by the Immunization Action Coalition.)

Did you know that approximately three million Americans are infected with the hepatitis C virus (HCV)? To learn more, check out CDC's interactive web-based training program titled "Hepatitis C: What Clinicians and Other Health Professionals Need to Know."

This program provides up-to-date information on HCV to primary care physicians, infectious disease specialists, blood bank staff, public health professionals, and other health care professionals. The program is designed to describe the natural history of HCV infection, the risk factors for acquiring HCV infection, and the tests used in diagnosis and evaluation. It includes discussion on treatment options for patients with chronic hepatitis C and the most effective methods to use in counseling patients with HCV infection.

Study questions and case studies let users test their understanding of the material. Continuing medical and nursing education credits are available free from CDC.

The CDC's Hepatitis Branch website also includes fact sheets and other materials on all types of viral hepatitis.

Editor’s Note:

Additional information is also available on the Bureau of Epidemiology web site.

 

6. Weekly Arbovirus Activity Summary

Robin Oliveri, Arbovirus Surveillance Coordinator and Dr. Lisa Conti, State Public Health Veterinarian

West Nile Virus (WNV) has now been detected as far south as North Carolina (in a crow near Raleigh). To date, WNV has not been detected in Florida.

There are currently no Arbovirus Medical Alerts issued for the state. During the period October 15 through October 20, 2000, the following arbovirus* activity was recorded for Florida:

(*Mosquito-borne virus including St. Louis encephalitis virus, Eastern Equine encephalitis virus, West Nile encephalitis virus and dengue virus)

Sentinel chickens: Fifteen sentinel chicken seroconversions to SLE were identified (565 chickens tested. (Source: DOH Tampa Laboratory from mosquito control agencies and county health departments). See attached figure.

 

Bird Mortality: 3 dead bird reports were entered into the bird mortality database (Monroe-1, Orange-1 and Sarasota-1). Although we are collecting information about any dead bird, at this time, the DOH is testing birds that have died within 24 hours prior to report. (Source: Florida Fish and Wildlife Conservation Commission web site).

 

7. New Legionellosis Case Report Form

In August 1999, the CDC issued a revised Legionellosis Case Report form (CDC 52.56). All county health department epidemiology staff should begin using this revised form.

 

8. Weekly Disease Table: Week 42

County-Confirmed Cases, Sorted Alphabetically by Disease

(NR represents years that the disease lacked status as a reportable condition)

DISEASE

1997 TO DATE

1998 TO DATE

1999 TO DATE

3 YEAR AVERAGE

TO DATE

1999 TOTAL CASES

2000 TO DATE

Anthrax

0

0

0

0

0

0

Botulism

0

0

3

1

4

0

Brucellosis

0

3

2

1.7

3

2

Campylobacteriosis

805

636

729

723.3

988

765

Ciguatera

9

7

2

6

2

12

Cryptosporidiosis

113

131

129

124.3

180

131

Cyclosporiasis

66

6

3

25

5

6

Dengue

3

4

3

3.3

3

3

Diphtheria

0

0

0

0

0

0

E. coli O157:H7

42

39

46

42.3

55

75

E. coli, other (known serotype)

6

5

13

8

15

11

Ehrlichiosis, Human

2

0

2

1.3

2

3

Encephalitis, Eastern Equine

2

0

2

1.3

3

0

Encephalitis, St. Louis

6

0

2

2.7

4

0

Encephalitis, post-infectious1

11

6

3

6.7

5

5

Encephalitis, other (known organism)

10

14

6

10

14

6

Giardiasis (acute)

1288

1142

941

1123.7

1322

1065

Haemophilus influenzae, invasive1

21

32

38

30.3

52

47

Hansen’s Disease (Leprosy)

0

4

3

2.3

3

4

Hantavirus Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

4

11

7

7.3

7

9

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

429

412

556

465.7

796

399

Hepatitis B

302

325

328

318.3

528

373

Hepatitis C

NR

NR

39

NR

55

22

Hepatitis Non-A, Non-B

76

71

6

51

10

6

Hepatitis, perinatal B

NR

NR

2

NR

 

3

Hepatitis, unspecified

6

18

10

2

17

7

Hepatitis, +HBsAg, pregnant woman

NR

NR

239

NR

448

341

Lead Poisoning

1133

1476

1377

1328.7

1810

754

Legionellosis

20

27

19

22

27

40

Leptospirosis

0

1

1

0.7

1

1

Listeriosis

NR

NR

25

NR

37

26

Lyme Disease

26

36

27

29.7

51

37

Malaria

61

57

69

62.3

97

64

Measles

6

2

2

3.3

2

1

Meningococcal Disease (N. meningitidis)

123

102

90

105

122

91

Meningitis, Group B Streptococci

12

15

11

12.7

14

15

Meningitis, Haemophilus influenzae1

10

11

12

11

13

7

Meningitis, Streptococcus pneumoniae

63

66

78

69

97

74

Meningitis, Listeria monocytogenes

2

4

7

4.3

14

5

Meningitis, other bacterial (including unspecified)

49

47

47

47.7

62

81

Mercury Poisoning

2

0

4

2

7

9

Mumps

9

10

3

7.3

6

2

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

56

35

66

52.3

85

42

Plague

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

2

0

0.7

0

0

Q Fever2

NR

NR

NR

NR

0

0

Rabies, Animal

229

166

158

184.3

186

140

Rocky Mountain Spotted Fever

3

1

2

2

2

4

Rubella, including congenital

3

4

0

2.3

1

3

Salmonellosis

1726

2067

2141

1978

3071

2047

Shigellosis

1134

1743

1108

1328.3

1491

1030

Smallpox

NR

NR

0

NR

0

0

Staphylococcus aureus, (GISA/VISA)

NR

NR

0

NR

0

0

Staphylococcus aureus, (GRSA/VRSA)

NR

NR

0

NR

0

0

Streptococcal Disease, invasive Group A

28

35

57

40

94

108

Streptococcus pneumoniae, invasive disease, drug resistant

165

330

437

310.7

700

790

Tetanus

1

3

2

2

3

1

Toxoplasmosis

5

10

13

9.3

17

8

Typhoid Fever

11

12

23

15.3

23

9

Vibrio cholerae (serogrp O1)

0

0

0

0

0

0

Vibrio cholerae (serogrp Non-O1)

8

6

9

7.7

10

4

Vibrio vulnificus

15

23

18

18.7

23

10

Vibrio other (including unspecified)

23

57

33

37.7

48

32

Yellow Fever

0

0

0

0

0

0

1 Haemophilus influenzae can be the agent responsible for disease under three of the reportable conditions listed-: "Haemophilus influenzae, invasive" and under "Encephalitis, post infectious." Cases of Haemophilus influenzae meningitis are reported under "Meningitis, H. influenzae."

2 The reportable disease rule was revised in June 2000. Amebiasis and Toxic Shock Syndrome (Staphylococcal and Streptococcal) were deleted from the list of reportable diseases. Q Fever was added to the list of reportable diseases.

This page was last modified on: 10/29/2012 03:40:13